Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers
Open Access
- 23 November 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 12629
Abstract
Cancer therapies targeting the vascular endothelial growth factor (VEGF) signaling pathway can lead to renal damage by disrupting the glomerular ultrafiltration apparatus. The objective of the current study was to identify sensitive biomarkers for VEGF inhibition-induced glomerular changes in rats. Male Sprague-Dawley rats were administered an experimental VEGF receptor (VEGFR) inhibitor, ABT-123, for seven days to investigate the correlation of several biomarkers with microscopic and ultrastructural changes. Glomeruli obtained by laser capture microdissection were also subjected to gene expression analysis to investigate the underlying molecular events of VEGFR inhibition in glomerulus. ABT-123 induced characteristic glomerular ultrastructural changes in rats, including fusion of podocyte foot processes, the presence of subendothelial electron-dense deposits, and swelling and loss of fenestrations in glomerular endothelium. The subtle morphological changes cannot be detected with light microscopy or by changes in standard clinical chemistry and urinalysis. However, urinary albumin increased 44-fold as early as Day three. Urinary β2-microglobulin levels were also increased. Other urinary biomarkers that are typically associated with tubular injury were not significantly impacted. Such patterns in urinary biomarkers can provide valuable diagnostic insight to VEGF inhibition therapy-induced glomeruli injuries.Keywords
This publication has 33 references indexed in Scilit:
- Mechanisms of Glomerular Albumin Filtration and Tubular ReabsorptionInternational Journal of Nephrology, 2012
- Renal cortical albumin gene induction and urinary albumin excretion in response to acute kidney injuryAmerican Journal of Physiology-Renal Physiology, 2011
- Bevacizumab Increases Risk for Severe Proteinuria in Cancer PatientsJournal of the American Society of Nephrology, 2010
- Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studiesNature Biotechnology, 2010
- VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and managementEuropean Journal of Cancer, 2010
- Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinibNephrology Dialysis Transplantation, 2008
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditionsProceedings of the National Academy of Sciences, 2007
- Urinary Excretion of β2-Microglobulin and IgG Predict Prognosis in Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2005
- Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces ProteinuriaJournal of Biological Chemistry, 2003